Pages that link to "Q59548827"
Jump to navigation
Jump to search
The following pages link to Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus (Q59548827):
Displaying 50 items.
- Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies (Q24531993) (← links)
- Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia (Q24680712) (← links)
- Ovarian surface epithelium: family history and early events in ovarian cancer (Q24791495) (← links)
- 13th General Meeting of The Breast Cancer Linkage Consortium, November 29-December 1, 1999, Amsterdam, The Netherlands (Q24803103) (← links)
- Dynamic mutation: possible mechanisms and significance in human disease (Q28256437) (← links)
- Human chromosomal fragile site FRA16B is an amplified AT-rich minisatellite repeat (Q28304011) (← links)
- BRCA1 and BRCA2 testing: weighing the demand against the benefits (Q28387366) (← links)
- Breast cancer risk and environmental exposures (Q28388844) (← links)
- LRP130, a protein containing nine pentatricopeptide repeat motifs, interacts with a single-stranded cytosine-rich sequence of mouse hypervariable minisatellite Pc-1 (Q28506266) (← links)
- A novel BRCA1 mutation in an identical twin pair with similar clinical histories (Q30471451) (← links)
- Epigenetic regulation of RhoB loss of expression in lung cancer (Q33307820) (← links)
- Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent (Q33327591) (← links)
- Genetic susceptibility testing and prophylactic oophorectomy (Q33595704) (← links)
- Laboratory identification of hereditary risk of breast and ovarian cancer (Q33653359) (← links)
- Mutation analysis of the BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sites (Q33677871) (← links)
- Genes implicated in hereditary breast cancer syndromes (Q33915583) (← links)
- The genetics of inherited breast cancer (Q33923794) (← links)
- Screening and clinical implications for BRCA1 and BRCA2 mutation carriers (Q33923799) (← links)
- Prophylactic oophorectomy: clinical considerations (Q33959816) (← links)
- Breast cancer genetics. Implications of clinical practice (Q34154250) (← links)
- Breast cancer genetics: what we know and what we need (Q34236139) (← links)
- Host susceptibility to cancer progression (Q34386296) (← links)
- An analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease: evidence for modifier effects (Q34387297) (← links)
- A bioinformatics-based strategy identifies c-Myc and Cdc25A as candidates for the Apmt mammary tumor latency modifiers (Q34411614) (← links)
- Cancer as a complex genetic trait: tumor susceptibility in humans and mouse models (Q34520426) (← links)
- Modifiers of risk of hereditary breast cancer (Q34568559) (← links)
- Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population (Q34574542) (← links)
- Inherited predisposition and breast cancer: modifiers of BRCA1/2-associated breast cancer risk (Q34580741) (← links)
- Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: a meta-analysis (Q34638831) (← links)
- Simple sequence repeats as a source of quantitative genetic variation (Q34738348) (← links)
- Beyond Mendel: an evolving view of human genetic disease transmission (Q34932051) (← links)
- Modifiers of risk of hereditary breast and ovarian cancer (Q35084790) (← links)
- Interactions between genetic and reproductive factors in breast cancer risk in a French family sample. (Q35249388) (← links)
- A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer (Q35431445) (← links)
- BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age. (Q35437468) (← links)
- Hereditary ovarian cancer in Ashkenazi Jews (Q35934068) (← links)
- Susceptibility to endometrial cancer: influence of allelism at p53, glutathione S-transferase (GSTM1 and GSTT1) and cytochrome P-450 (CYP1A1) loci (Q36431685) (← links)
- Heterozygous screen in Saccharomyces cerevisiae identifies dosage-sensitive genes that affect chromosome stability (Q36515688) (← links)
- Induction of minisatellite mutation in NIH 3T3 cells by treatment with the tumor promoter okadaic acid (Q36596063) (← links)
- Allelotype influence at glutathione S-transferase M1 locus on breast cancer susceptibility (Q36617324) (← links)
- Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations (Q36641252) (← links)
- Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer (Q36643361) (← links)
- E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium (Q37202994) (← links)
- Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers (Q37362211) (← links)
- Gene expression profiles and breast cancer metastasis: a genetic perspective (Q37434078) (← links)
- Phenotype and sarcoglycan expression in Tunisian LGMD 2C patients sharing the same del521-T mutation (Q39126349) (← links)
- Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families (Q41193996) (← links)
- Mutations of the BRCA1 and BRCA2 genes and the possibilities for predictive testing (Q41457953) (← links)
- Expression of ras proto-oncogenes: regulation and implications in the development of human tumors (Q41594629) (← links)
- Tumor suppressor genes and human cancer (Q41625163) (← links)